LENZ Latest Press Releases

-- October 28, 2026 --

LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession Globe Newswire 4:30 PM

-- October 22, 2026 --

LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026 Globe Newswire 8:00 AM

-- October 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ Globe Newswire 6:27 PM

-- September 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ PRNewswire 5:35 PM

-- September 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ Globe Newswire 6:15 PM

-- September 3, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ PRNewswire 10:16 AM

-- September 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ Globe Newswire 5:31 PM

-- August 11, 2026 --

LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- August 4, 2026 --

LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 Globe Newswire 4:05 PM

-- July 6, 2026 --

LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ for the Treatment of Presbyopia Globe Newswire 8:15 AM

-- June 24, 2026 --

LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ in Australia and New Zealand Globe Newswire 8:30 AM

-- June 7, 2026 --

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ (LNZ100) in Greater China Globe Newswire 7:30 PM

Market Data Delayed 15 Minutes